Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors

• Dafu Yang,
• Dan Li,
• Zhaoxia Dai,
• Yutong Ma,
• Qiuxiang Ou,
• Xue Wu,
• Saiqiong Cui

Affiliations

Dafu Yang

The Second Department of Thoracic Medical Oncology The Second Hospital of Dalian Medical University Dalian Liaoning 116027 P. R. China

Dan Li

The Second Department of Thoracic Medical Oncology The Second Hospital of Dalian Medical University Dalian Liaoning 116027 P. R. China

Zhaoxia Dai

The Second Department of Thoracic Medical Oncology The Second Hospital of Dalian Medical University Dalian Liaoning 116027 P. R. China

Yutong Ma

Translational Medicine Research Institute Geneseeq Technology Inc Toronto Ontario M5G 1L7 Canada

Qiuxiang Ou

Translational Medicine Research Institute Geneseeq Technology Inc Toronto Ontario M5G 1L7 Canada

Xue Wu

Translational Medicine Research Institute Geneseeq Technology Inc Toronto Ontario M5G 1L7 Canada

Saiqiong Cui

The Second Department of Thoracic Medical Oncology The Second Hospital of Dalian Medical University Dalian Liaoning 116027 P. R. China